Rationale: In cystic fibrosis (CF), the lung clearance index (LCI), derived from multiple breath washout (MBW), is more sensitive in detecting early lung disease than FEV1; MBW has been less thoroughly evaluated in young patients with primary ciliary dyskinesia (PCD). Objectives: Our objectives were 1) to evaluate the sensitivity of MBW and spirometry for the detection of mild lung disease in young children with PCD and CF compared with healthy control (HC) subjects and 2) to compare patterns of airway obstruction between disease populations. Methods: We used a multicenter, single-visit, observational study in children with PCD and CF with a forced expiratory volume in 1 second (FEV1) greater than 60% predicted and HC subjects, ages 3-12 years. Nitrogen MBW and spirometry were performed and overread for acceptability. χ2 and Kruskall-Wallis tests compared demographics and lung function measures between groups, linear regression evaluated the effect of disease state, and Spearman's rank correlation coefficient compared the LCI and spirometric measurements. Results: Twenty-five children with PCD, 49 children with CF, and 80 HC children were enrolled, among whom 17 children with PCD (68%), 36 children with CF (73%), and 53 (66%) HC children performed both acceptable spirometry and MBW; these children made up the analytic cohort. The median age was 9.0 years (interquartile range [IQR], 6.8-11.1). The LCI was abnormal (more than 7.8) in 10 of 17 (59%) patients with PCD and 21 of 36 (58%) patients with CF, whereas FEV1 was abnormal in three of 17 (18%) patients with PCD and six of 36 (17%) patients with CF. The LCI was significantly elevated in patients with PCD and CF compared with HC subjects (ratio of geometric mean vs. HC: PCD 1.27; 95% confidence interval [CI], 1.15-1.39; and CF 1.24; 95% CI, 1.15-1.33]). Children with PCD had lower midexpiratory-phase forced expiratory flow % predicted compared with children with CF (62% [IQR, 50-78%] vs. 85% [IQR, 68-99%]; P = 0.05). LCI did not correlate with FEV1.Conclusions: The LCI is more sensitive than FEV1 in detecting lung disease in young patients with PCD, similar to CF. LCI holds promise as a sensitive endpoint for the assessment of early PCD lung disease.
Rationale: In cystic fibrosis (CF), the lung clearance index (LCI), derived from multiple breath washout (MBW), is more sensitive in detecting early lung disease than FEV1; MBW has been less thoroughly evaluated in young patients with primary ciliary dyskinesia (PCD). Objectives: Our objectives were 1) to evaluate the sensitivity of MBW and spirometry for the detection of mild lung disease in young children with PCD and CF compared with healthy control (HC) subjects and 2) to compare patterns of airway obstruction between disease populations. Methods: We used a multicenter, single-visit, observational study in children with PCD and CF with a forced expiratory volume in 1 second (FEV1) greater than 60% predicted and HC subjects, ages 3-12 years. Nitrogen MBW and spirometry were performed and overread for acceptability. χ2 and Kruskall-Wallis tests compared demographics and lung function measures between groups, linear regression evaluated the effect of disease state, and Spearman's rank correlation coefficient compared the LCI and spirometric measurements. Results: Twenty-five children with PCD, 49 children with CF, and 80 HC children were enrolled, among whom 17 children with PCD (68%), 36 children with CF (73%), and 53 (66%) HC children performed both acceptable spirometry and MBW; these children made up the analytic cohort. The median age was 9.0 years (interquartile range [IQR], 6.8-11.1). The LCI was abnormal (more than 7.8) in 10 of 17 (59%) patients with PCD and 21 of 36 (58%) patients with CF, whereas FEV1 was abnormal in three of 17 (18%) patients with PCD and six of 36 (17%) patients with CF. The LCI was significantly elevated in patients with PCD and CF compared with HC subjects (ratio of geometric mean vs. HC: PCD 1.27; 95% confidence interval [CI], 1.15-1.39; and CF 1.24; 95% CI, 1.15-1.33]). Children with PCD had lower midexpiratory-phase forced expiratory flow % predicted compared with children with CF (62% [IQR, 50-78%] vs. 85% [IQR, 68-99%]; P = 0.05). LCI did not correlate with FEV1.Conclusions: The LCI is more sensitive than FEV1 in detecting lung disease in young patients with PCD, similar to CF. LCI holds promise as a sensitive endpoint for the assessment of early PCD lung disease.
Authors: Paul D Robinson; Philipp Latzin; Sylvia Verbanck; Graham L Hall; Alexander Horsley; Monika Gappa; Cindy Thamrin; Hubertus G M Arets; Paul Aurora; Susanne I Fuchs; Gregory G King; Sooky Lum; Kenneth Macleod; Manuel Paiva; Jane J Pillow; Sarath Ranganathan; Sarah Ranganathan; Felix Ratjen; Florian Singer; Samatha Sonnappa; Janet Stocks; Padmaja Subbarao; Bruce R Thompson; Per M Gustafsson Journal: Eur Respir J Date: 2013-02-08 Impact factor: 16.671
Authors: Bruce H Culver; Brian L Graham; Allan L Coates; Jack Wanger; Cristine E Berry; Patricia K Clarke; Teal S Hallstrand; John L Hankinson; David A Kaminsky; Neil R MacIntyre; Meredith C McCormack; Margaret Rosenfeld; Sanja Stanojevic; Daniel J Weiner Journal: Am J Respir Crit Care Med Date: 2017-12-01 Impact factor: 21.405
Authors: Philip H Quanjer; Sanja Stanojevic; Tim J Cole; Xaver Baur; Graham L Hall; Bruce H Culver; Paul L Enright; John L Hankinson; Mary S M Ip; Jinping Zheng; Janet Stocks Journal: Eur Respir J Date: 2012-06-27 Impact factor: 16.671
Authors: Samantha J Irving; Andrew Ives; Gwyneth Davies; Jackie Donovan; Anthony J Edey; Simon S Gill; Arjun Nair; Clare Saunders; Nevin T Wijesekera; Eric W F W Alton; David Hansell; Claire Hogg; Jane C Davies; Andrew Bush Journal: Am J Respir Crit Care Med Date: 2013-09-01 Impact factor: 21.405
Authors: Florian S Halbeisen; Myrofora Goutaki; Ben D Spycher; Israel Amirav; Laura Behan; Mieke Boon; Claire Hogg; Carmen Casaulta; Suzanne Crowley; Eric G Haarman; Bulent Karadag; Cordula Koerner-Rettberg; Michael R Loebinger; Henryk Mazurek; Lucy Morgan; Kim G Nielsen; Heymut Omran; Francesca Santamaria; Nicolaus Schwerk; Guillaume Thouvenin; Panayiotis Yiallouros; Jane S Lucas; Philipp Latzin; Claudia E Kuehni Journal: Eur Respir J Date: 2018-08-23 Impact factor: 16.671
Authors: Erick Forno; Steven H Abman; Jagdev Singh; Mary E Robbins; Hiran Selvadurai; Paul T Schumacker; Paul D Robinson Journal: Am J Respir Crit Care Med Date: 2021-08-01 Impact factor: 30.528
Authors: Eva S L Pedersen; Eugénie N R Collaud; Rebeca Mozun; Cristina Ardura-Garcia; Yin Ting Lam; Amanda Harris; Jane S Lucas; Fiona Copeland; Michele Manion; Bernhard Rindlisbacher; Hansruedi Silberschmidt; Myrofora Goutaki; Claudia E Kuehni Journal: ERJ Open Res Date: 2021-03-22
Authors: Kim G Nielsen; Mathias G Holgersen; Suzanne Crowley; June K Marthin Journal: Am J Med Genet C Semin Med Genet Date: 2022-03-29 Impact factor: 3.359